Sonnet Biotherapeutics Holdings Stock Price Prediction
| SONN Stock | USD 2.79 0.19 6.38% |
Oversold Vs Overbought
28
Oversold | Overbought |
EPS Estimate Next Quarter (0.63) | EPS Estimate Current Year (12.88) | EPS Estimate Next Year (14.96) | Wall Street Target Price 240 | EPS Estimate Current Quarter (0.76) |
Using Sonnet Biotherapeutics hype-based prediction, you can estimate the value of Sonnet Biotherapeutics Holdings from the perspective of Sonnet Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sonnet Biotherapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Sonnet because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sonnet Biotherapeutics after-hype prediction price | USD 3.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sonnet |
Sonnet Biotherapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Sonnet Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sonnet Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sonnet Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sonnet Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Sonnet Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sonnet Biotherapeutics' historical news coverage. Sonnet Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.20 and 10.86, respectively. We have considered Sonnet Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sonnet Biotherapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Sonnet Biotherapeutics is based on 3 months time horizon.
Sonnet Biotherapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sonnet Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sonnet Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sonnet Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.88 | 6.87 | 1.01 | 0.05 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.79 | 3.99 | 33.89 |
|
Sonnet Biotherapeutics Hype Timeline
Sonnet Biotherapeutics is at this time traded for 2.79. The entity has historical hype elasticity of 1.01, and average elasticity to hype of competition of -0.05. Sonnet is estimated to increase in value after the next headline, with the price projected to jump to 3.99 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 33.89%, whereas the daily expected return is at this time at -0.88%. The volatility of related hype on Sonnet Biotherapeutics is about 13085.71%, with the expected price after the next announcement by competition of 2.74. Sonnet Biotherapeutics Holdings currently holds 203.91 K in liabilities with Debt to Equity (D/E) ratio of 0.36, which is about average as compared to similar companies. Sonnet Biotherapeutics has a current ratio of 1.08, suggesting that it may have difficulties to pay its financial obligations when due. Note, when we think about Sonnet Biotherapeutics' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Sonnet Biotherapeutics Basic Forecasting Models to cross-verify your projections.Sonnet Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Sonnet Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Sonnet Biotherapeutics' future price movements. Getting to know how Sonnet Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sonnet Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| YS | YS Biopharma Co, | 0.12 | 2 per month | 0.00 | (0.10) | 10.29 | (10.53) | 36.81 | |
| ZVSA | ZyVersa Therapeutics | (0.1) | 5 per month | 0.00 | (0.15) | 7.57 | (9.60) | 78.93 | |
| ALLR | Allarity Therapeutics | 0.07 | 10 per month | 0.00 | (0.27) | 10.85 | (16.11) | 41.48 | |
| KRBP | Kiromic Biopharma | (0.24) | 3 per month | 0.00 | (0.03) | 12.04 | (10.96) | 65.24 | |
| IMMX | Immix Biopharma | (0.03) | 3 per month | 0.00 | (0.06) | 7.06 | (8.22) | 32.68 | |
| CNSP | Cns Pharmaceuticals | (0.18) | 7 per month | 0.00 | (0.05) | 9.09 | (11.76) | 39.29 | |
| EFTR | Effector Therapeutics | (0.06) | 4 per month | 0.00 | (0.31) | 8.70 | (27.78) | 88.91 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.15) | 12.50 | (12.50) | 40.40 |
Sonnet Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Sonnet price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sonnet using various technical indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sonnet Biotherapeutics Predictive Indicators
The successful prediction of Sonnet Biotherapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sonnet Biotherapeutics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sonnet Biotherapeutics based on analysis of Sonnet Biotherapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sonnet Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sonnet Biotherapeutics's related companies. | 2021 | 2024 (projected) | Interest Debt Per Share | 0.003788 | 29.4K | Revenue Per Share | 1.77 | 91.8K |
Story Coverage note for Sonnet Biotherapeutics
The number of cover stories for Sonnet Biotherapeutics depends on current market conditions and Sonnet Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sonnet Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sonnet Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sonnet Biotherapeutics Short Properties
Sonnet Biotherapeutics' future price predictability will typically decrease when Sonnet Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sonnet Biotherapeutics Holdings often depends not only on the future outlook of the potential Sonnet Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sonnet Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 2.3 M |
Check out Sonnet Biotherapeutics Basic Forecasting Models to cross-verify your projections. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.